Stryker completes sale of U.S. spinal implants business
Stryker (NYSE: SYK) has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, , which will operate under the newly formed VB Spine, . The strategic divestment aims to enhance Stryker's focus and enable investments in areas with greater innovation and growth potential.
As part of the agreement, VB Spine will have exclusive access to Mako Spine and Copilot technologies for spine procedures. Stryker maintains its presence in the spine sector through its Interventional Spine, Neurotechnology, and Enabling Technologies businesses, along with a strategic partnership with VB Spine.
The transaction's international component will be executed in phases, with transfers to VB Spine in certain markets pending legal, regulatory, and employee consultation requirements.
Stryker (NYSE: SYK) ha completato la vendita della sua attività di impianti spinali negli Stati Uniti a Viscogliosi Brothers, che opererà sotto il nuovo nome di VB Spine. Questa dismissione strategica ha l'obiettivo di migliorare il focus di Stryker e consentire investimenti in aree con maggiore innovazione e potenziale di crescita.
Come parte dell'accordo, VB Spine avrà accesso esclusivo alle tecnologie Mako Spine e Copilot per le procedure spinali. Stryker mantiene la sua presenza nel settore spinale attraverso le sue attività di Spine Interventionale, Neurotecnologia e Tecnologie Abilitanti, insieme a una partnership strategica con VB Spine.
La componente internazionale della transazione sarà eseguita in fasi, con trasferimenti a VB Spine in determinati mercati in attesa di requisiti legali, normativi e di consultazione dei dipendenti.
Stryker (NYSE: SYK) ha completado la venta de su negocio de implantes espinales en EE. UU. a Viscogliosi Brothers, que operará bajo el nuevo nombre de VB Spine. Esta desinversión estratégica tiene como objetivo mejorar el enfoque de Stryker y permitir inversiones en áreas con mayor innovación y potencial de crecimiento.
Como parte del acuerdo, VB Spine tendrá acceso exclusivo a las tecnologías Mako Spine y Copilot para procedimientos de columna. Stryker mantiene su presencia en el sector de la columna a través de sus negocios de Columna Intervencionista, Neurotecnología y Tecnologías Habilitadoras, junto con una asociación estratégica con VB Spine.
El componente internacional de la transacción se llevará a cabo en fases, con transferencias a VB Spine en ciertos mercados pendientes de requisitos legales, regulatorios y de consulta a los empleados.
Stryker (NYSE: SYK)는 미국의 척추 임플란트 사업을 Viscogliosi Brothers에 매각하였으며, 이 회사는 새롭게 설립된 VB Spine으로 운영될 것입니다. 이 전략적 매각은 Stryker의 집중력을 높이고 더 큰 혁신과 성장 잠재력이 있는 분야에 대한 투자를 가능하게 하는 것을 목표로 합니다.
계약의 일환으로, VB Spine은 척추 수술을 위한 Mako Spine 및 Copilot 기술에 대한 독점적 접근 권한을 갖게 됩니다. Stryker는 척추 분야에서 Interventional Spine, Neurotechnology 및 Enabling Technologies 사업을 통해 존재감을 유지하며, VB Spine과의 전략적 파트너십도 유지하고 있습니다.
거래의 국제적인 구성 요소는 단계적으로 실행되며, 특정 시장에서 VB Spine으로의 이전은 법적, 규제 및 직원 상담 요구 사항에 따라 진행됩니다.
Stryker (NYSE: SYK) a finalisé la vente de son activité d'implants vertébraux aux États-Unis à Viscogliosi Brothers, qui opérera sous le nouveau nom de VB Spine. Cette désinvestissement stratégique vise à renforcer l'accent mis par Stryker et à permettre des investissements dans des domaines présentant un potentiel d'innovation et de croissance plus important.
Dans le cadre de l'accord, VB Spine aura un accès exclusif aux technologies Mako Spine et Copilot pour les procédures de colonne vertébrale. Stryker maintient sa présence dans le secteur de la colonne vertébrale grâce à ses activités en Spine Interventionnelle, Neurotechnologie et Technologies Facilitantes, ainsi qu'à un partenariat stratégique avec VB Spine.
La composante internationale de la transaction sera exécutée par phases, avec des transferts à VB Spine sur certains marchés en attente des exigences légales, réglementaires et de consultation des employés.
Stryker (NYSE: SYK) hat den Verkauf seines US-amerikanischen Geschäfts mit Spinalimplantaten an Viscogliosi Brothers abgeschlossen, das unter dem neu gegründeten Namen VB Spine operieren wird. Diese strategische Veräußerung zielt darauf ab, den Fokus von Stryker zu verbessern und Investitionen in Bereiche mit größerer Innovation und Wachstumspotenzial zu ermöglichen.
Im Rahmen der Vereinbarung wird VB Spine exklusiven Zugang zu den Technologien Mako Spine und Copilot für Wirbelsäulenverfahren erhalten. Stryker bleibt im Wirbelsäulenbereich durch seine Geschäfte in Interventional Spine, Neurotechnology und Enabling Technologies sowie durch eine strategische Partnerschaft mit VB Spine präsent.
Der internationale Bestandteil der Transaktion wird in Phasen durchgeführt, wobei Übertragungen an VB Spine in bestimmten Märkten aufgrund rechtlicher, regulatorischer und Mitarbeiterkonsultationsanforderungen ausstehen.
- Strategic divestment allows focus on higher-growth opportunities
- Maintains revenue potential through strategic partnership with VB Spine
- Retains presence in spine market through other business segments
- Loss of direct revenue from U.S. spinal implants business
- Delayed international market transitions may impact overall deal completion timeline
Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC.
“The sale of our spinal implants business enhances our strategic focus, positioning us to meet evolving customer needs and invest where we see the greatest opportunity for innovation and long-term growth,” said Kevin Lobo, Chair and CEO, Stryker. “We remain committed to the spine space through our Interventional Spine, Neurotechnology and Enabling Technologies businesses, as well as our strategic partnership with VB Spine. We’re grateful to our Spine team members for their contributions and confident they’re well positioned for continued success.”
VB Spine will have exclusive access to Mako Spine and Copilot for use with its implants in spine procedures.
Certain international markets are expected to transfer to VB Spine at later dates, subject to the completion of all legal and regulatory requirements and required consultations with employees and/or employee representatives.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:
Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries:
Kim Montagnino, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com
FAQ
What assets did Stryker (SYK) sell to VB Spine in April 2025?
Will Stryker (SYK) completely exit the spine market after this sale?
What technology access does VB Spine receive in the Stryker (SYK) deal?
How will the international markets transition in the Stryker (SYK) spine business sale?
